.
MergerLinks Header Logo

New Deal


Announced

Kadenwood to acquire EcoGen Laboratories.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pharmaceuticals

United States

Majority

Private

cannabis

Acquisition

Friendly

Single Bidder

Pending

Synopsis

Edit

Kadenwood, a consumer seed-to-shelf CBD company, agreed to acquire EcoGen Laboratories, the global manufacturer and supplier of hemp-derived CBD materials and formulations. The acquisition aims to create an integrated supplier worth c. $250m. Financial terms were not disclosed. "We're committed to improving not just our brand, but the perception of our industry overall, and that starts with ensuring consumers have access to quality CBD products they can trust. EcoGen has maintained a commitment to producing sustainable and consistent CBD and we're happy to bring them under the Kadenwood brand as we expand our offering of exceptionally pure CBD products that continue to set the industry's standard of quality," Erick Dickens, Kadenwood CEO and Co-Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US